Blinding, Randomization and Supply

Part of Clinical Trial Assistant (CTA) Training: Supply Forecasting and Stockouts.

About 4 minutes. Free, in your language, no account needed.

Why this matters

In a blinded study, supply and blinding are the same problem. Every decision about which units go where has the potential to reveal something, and the people making supply decisions are often the people best placed to work out the allocation.

How supply can break a blind

Distinguishable product. Active and comparator that differ in appearance, smell, packaging weight or reconstitution behavior. This is a design problem, but it shows up in handling.

Kit numbering patterns. If kits are allocated in a way that correlates with arm, someone who sees enough numbers can infer the pattern.

Differential consumption. If one arm runs out faster because of a dosing difference, stock levels themselves carry information.

Well-meaning conversation. Somebody mentions that a site needs more of a particular lot. That sentence can be enough.

Your position

Most CTAs are blinded, and should stay that way. Where an unblinded supply role exists it is defined, documented and firewalled from the people who assess outcomes.

Two practical rules follow.

Do not go looking. Curiosity about which participant is on what is understandable and is exactly the behavior the design exists to prevent.

If you learn something you should not have, say so immediately to the study manager. An accidental unblinding that is reported can be managed: the person is removed from relevant decisions and it is documented. An accidental unblinding that is concealed contaminates everything that person touches afterwards.

Emergency unblinding

Protocols provide a route for unblinding when knowing the allocation is necessary for a participant's medical management. That decision belongs to the investigator, not to supply.

What you need to know is that the route works. The system is accessible, the site knows how to use it, and the process records who unblinded, when and why. Test that at activation rather than discovering at 02:00 that nobody has the credentials.

Randomization and resupply

Many studies resupply automatically against randomization, which is efficient and hides a risk: if the enrollment assumptions in the system are wrong, it will keep shipping the wrong quantities to the wrong places and nobody will notice because it is automatic.

Check that the system's assumptions match reality periodically. Automation removes effort, not responsibility.

In practice

You notice that site 402 has consumed comparator kits noticeably faster than site 401 across three resupply cycles.

Two thoughts follow, and only one of them is safe.

The unsafe thought is the inference: if consumption differs, the allocation at those sites may differ, and you are now holding information about the trial you should not have.

The safe action is to stop looking and report the observation as a supply anomaly, not as an allocation observation. "Consumption at 402 is running ahead of 401 by roughly 30% across three cycles, which does not match the enrollment difference" is a legitimate operational flag. Speculating in writing about what that implies for allocation is not.

Frequently the explanation is mundane: different visit scheduling, a participant on a higher titration, wastage, or a miscount. But the moment you start reasoning about arms, you are doing something the study design exists to prevent.

The system that hides the risk

Automated resupply against randomization is efficient precisely because nobody has to think about which kits go where. That is also its risk: if the enrollment forecast in the system is wrong, it will keep shipping confidently and the first sign will be a stockout or a pile of expiring stock.

Check periodically that the system's assumptions match reality. Enrollment rate, visit schedule, buffer level, expiry handling. Automation removed the effort, not the responsibility, and the person best placed to notice the drift is usually the one watching the shipments arrive.

Key takeaways